Connect with us

National

Risk, uncertainty and fear of failure: Why scientists aren’t celebrating a coronavirus vaccine yet – The Telegraph

Scientific community wrestling with how to deal with both public hesitancy and overblown expectations for a potential jab

Published

on

post featured image

The most advanced vaccine projects, including those of Oxford University and the US pharmaceutical company Moderna, are moving into large-scale Phase III trials in which any less common side effects or safety issues should become apparent.
Side effects are common and can cover a wide range of ailments, most of which are unwelcome but not a significant barrier to receiving a jab. Some, however, might be so rare as to not emerge until there is population-scale deployment of a vaccine.
Maurice Hi…

Click here to view the original article.